Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProShares Trust Ultra VIX Short Term Futures ETF UVXY

ARCA:UVXY - Post Discussion

Post by LongGuy on Mar 28, 2019 9:23am

HSGX

I found this last night and started doing a bit of dd on it. 

Seems to have bottomed out and popped yesterday and a few times this year days.   Heavy buying into the close yesterday. 

They are going into Phase 3 for restorative cell therapy "to rebuild a patient’s own knee cartilage to treat pain at the source and potentially prevent a patient’s progression to osteoarthritis"

https://www.histogenics.com/

https://nysenewstoday.com/2019/03/28/lets-make-some-money-with-histogenics-corporation-nasdaq-hsgx/

https://nysenasdaqnews.com/2019/03/28/not-too-big-not-too-small-this-one-is-just-right-histogenics-corporation-nasdaq-hsgx/

Something to keep on the burner while we are all focusing on TENX today.

glta.

LongGuy
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities